It is estimated that 80% of the world population trusts traditional medicine. A large number of Americans use infusions of Bocconia frutescens L. leaves to treat cough and gastrointestinal disorders. However, phytochemical studies reveal that this plant contains alkaloids and other potentially harmful substances. This study aimed to evaluate the teratogenic effects of B. frutescens L. in an experimental model. Pregnant Wistar rats were administered lyophilized B. frutescens L. extract at 300 mg/kg/day or vehicle by orogastric route during the organogenesis period (gestation days 7–13), and external and internal congenital malformations were analyzed on the progeny on gestational day 20. Bocconia frutescens L. produced a significant increase in the number of different malformations, relative to the control group. We conclude that the consumption of B. frutescens L. during pregnancy at a dose equivalent to that consumed by humans increases the risk of teratogenic effects.

Two studies were conducted to investigate the possibility that pteroylmonoglutamic acid supplementation would alleviate teratogenesis in zinc-deficient rats. Pregnant rats of the Wistar strain were fed on Zn-deficient (< 0.5 mg Zn/kg) or Zn-supplemented (75 or 95 mg Zn/kg) diets from mating until day 18.5 of gestation. The basal level of pteroylmonoglutamic acid added to all diets (0.56 mg/kg) was supplemented with 30–200 mg/kg in selected diets. Dietary Zn deprivation resulted in fetal resorption, fetal growth retardation and reduced concentrations of Zn in fetuses and maternal plasma and tibia. Low maternal body-weight at conception emerged as an important determinant of risk of resorption in Zn-deficient rats. Dietary Zn deficiency resulted in reduced maternal plasma folate concentrations and these values were inversely correlated with litter size or weight in Zn-deficient rats. Pteroylmonoglutamic acid supplementation increased maternal plasma folate concentrations, but did not reduce the high incidence of teratogenesis which occurred in Zn-deficient rats. Supplementation of Zn-deficient rats with pteroylmonoglutamic acid significantly increased the incidence of clubbed foot and tended to increase the incidence of brain or meningeal abnormalities, or both, and cleft palate, but did not reduce maternal or fetal Zn status. Pteroylmonoglutamic acid supplementation also increased the weights of Zn-supplemented control fetuses.

In recent years, it has been realized that some infants of frankly alcoholic mothers escape the stigmata of fetal alcohol syndrome (FAS) and others have only a few of the characteristics. These infants are thought to display fetal alcohol effects (FAE). The controversy regarding the amount of alcohol a woman can safely drink during pregnancy and the effects of timing and individual physiology on producing FAS vs FAE in the infant are important questions which can perhaps be partially answered through examining twin pregnancies and offspring. Data are presented regarding the long-term growth and development of a set of dizygotic twins, one with FAS and one with FAE, delivered to a mother who drank moderate amounts of alcohol during pregnancy. The variation in the degree of abnormality found in dizygotic twins exposed to similar amounts of alcohol at the same time during gestation indicates that differences in fetal susceptibility to ethanol dysmorphogenesis are of prime importance to the expression of the fetal alcohol syndrome.

Among 93 cases of thalidomide embryopathy ascertained in Brazil, one pair of female dizygotic twins was found. One of them presented complete paraxial hemimelia in the right arm while the other showed a triphalangeal thumb at the left hand and had duodenal stenosis. Of the eight dizygotic twin pairs exposed to thalidomide in utero described thus far, only four were concordant for the type of malformation.